Beneficial health effects of exercise - the role of IL-6 as a myokine

Trends in Pharmacological Sciences

Volumn 28, Issue 4, 2007, Pages 152-156

  Pedersen, Bente K ^a   Fischer, Christian P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERLEUKIN 6; INTERLEUKIN 8;

ANGIOGENESIS; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOCRINE GLAND; ENDURANCE; EXERCISE; GLUCONEOGENESIS; HUMAN; INFLAMMATION; METABOLIC DISORDER; MUSCLE CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; EXERCISE; HUMANS; INTERLEUKIN-6; MUSCLE CONTRACTION; MUSCLE, SKELETAL;

EID: 33947720482     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.02.002     Document Type: Article

References (40)

1. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
2. Blair S.N., et al. Is physical activity or physical fitness more important in defining health benefits?. Med. Sci. Sports Exerc. 33 (2001) S379-S399
3. Pedersen B.K., and Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand. J. Med. Sci. Sports 1 (2006) 3-63
4. Holmes M.D., et al. Physical activity and survival after breast cancer diagnosis. J. Am. Med. Assoc. 293 (2005) 2479-2486
5. Meyerhardt J.A., et al. Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24 (2006) 3527-3534
6. Mohr T., et al. Long-term adaptation to electrically induced cycle training in severe spinal cord injured individuals. Spinal Cord 35 (1997) 1-16
7. Kjaer M., et al. Hormonal and metabolic responses to electrically induced cycling during epidural anesthesia in humans. J. Appl. Physiol. 80 (1996) 2156-2162
8. Asmussen E. Exercise: general statement of unsolved problems. Circ. Res. 20 Suppl. 1 (1967) 12-15
9. Tilg H., et al. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18 (1997) 428-432
10. Petersen A.M., and Pedersen B.K. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98 (2005) 1154-1162
11. Febbraio M.A., and Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16 (2002) 1335-1347
12. Pedersen B.K., et al. Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J. Appl. Physiol. 102 (2007) 814-816
13. Pedersen B.K., and Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaption. Physiol. Rev. 80 (2000) 1055-1081
14. Pedersen B.K., et al. Searching for the exercise factor - is IL-6 a candidate?. J. Muscle Res. Cell Motil. 24 (2003) 113-119
15. Suzuki K., et al. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc. Immunol. Rev. 8 (2002) 6-48
16. Ostrowski K., et al. Physical activity and plasma interleukin-6 in humans - effect of intensity of exercise. Eur. J. Appl. Physiol. 83 (2000) 512-515
17. Ostrowski K., et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J. Physiol. 515 (1999) 287-291
18. Ostrowski K., et al. Evidence that IL-6 is produced in skeletal muscle during prolonged running. J. Physiol. 508 (1998) 949-953
19. Steensberg A., et al. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J. Physiol. 537 (2001) 633-639
20. Keller C., et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 15 (2001) 2748-2750
21. Hiscock N., et al. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J. 18 (2004) 992-994
22. Steensberg A., et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529 (2000) 237-242
23. Steensberg A., et al. IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E1272-E1278
24. Keller P., et al. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J. 19 (2005) 1181-1183
25. Starkie R., et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J. 17 (2003) 884-886
26. Plomgaard P., et al. TNF-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of AS160 phosphorylation. Diabetes 54 (2005) 2939-2945
27. Febbraio M.A., et al. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53 (2004) 1643-1648
28. Steensberg A., et al. Acute interleukin-6 administration does not impair muscle glucose uptake or whole body glucose disposal in healthy humans. J. Physiol. 548 (2003) 631-638
29. Lyngso D., et al. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J. Physiol. 543 (2002) 373-378
30. Akira S., et al. Interleukin-6 in biology and medicine. Adv. Immunol. 54 (1993) 1-78
31. Carey A.L., et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55 (2006) 2688-2697
32. van Hall G., et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88 (2003) 3005-3010
33. Nishimoto N., et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 50 (2004) 1761-1769
34. Choy E.H., et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 46 (2002) 3143-3150
35. Wallenius V., et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8 (2002) 75-79
36. Kahn B.B., et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
37. Kelly M., et al. AMPK activity is diminished in tissues of the IL-6 knockout mice: the effect of exercise. Biochem. Biophys. Res. Commun. 320 (2004) 449-454
38. Frydelund-Larsen L., et al. Muscle: exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle. Exp. Physiol. 92 (2007) 233-240
39. Akerstrom T., et al. Exercise induces interleukin-8 expression in human skeletal muscle. J. Physiol. 563 (2005) 507-516
40. Fischer C.P. Interleukin-6 in acute exercise and training: what is the biological relevance?. Exerc. Immunol. Rev. 12 (2006) 6-33